Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 3
1(25.0%)
N/A
1(25.0%)
Phase 2
1(25.0%)
Phase 1
1(25.0%)
4Total
Phase 3(1)
N/A(1)
Phase 2(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06743711Recruiting

Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

Role: lead

NCT06624462Not ApplicableRecruiting

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

Role: lead

NCT04789915Phase 1Recruiting

Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis

Role: lead

NCT03994965Phase 2Withdrawn

The Sub-Sero Study

Role: lead

NCT01794429Phase 3Completed

Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue

Role: lead

All 5 trials loaded